Research Article
BibTex RIS Cite
Year 2023, Volume: 6 Issue: 3, 693 - 698, 31.05.2023
https://doi.org/10.32322/jhsm.1293585

Abstract

References

  • Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T (4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-99.
  • Huber G, Staub JJ, Meier C, et al. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab 2002; 87: 3221-6.
  • Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005; 26: 662-87.
  • Li HS, Verginis P, Carayanniotis G. Maturation of dendritic cells by necrotic thyrocytes facilitates induction of experimental autoimmune thyroiditis. Clin Exp Immunol 2006; 144: 467-74.
  • Jo E-K. Innate immunity to mycobacteria: vitamin D and autophagy. Cell Microbiol 2010; 12: 1026-35.
  • Wang J, Lv S, Chen G, et al. Meta-Analysis of the association between Vitamin D and autoimmune thyroid disease. Nutrients 2015; 7: 2485-98
  • Cvek M, Kaličanin D, Barić A, et al. Vitamin D and Hashimoto’s thyroiditis: observations from CROHT Biobank. Nutrients 2021; 13: 2793.
  • Botelho IMB, Moura Neto A, Silva CA, Tambascia MA, Alegre SM, Zantut-Wittmann DE. Vitamin D in Hashimoto’s thyroiditis and its relationship with thyroid function and inflammatory status. Endocr J 2018; 65: 1029-37.
  • Seo IH, Lee YJ. Usefulness of complete blood count (CBC) to assess cardiovascular and metabolic diseases in clinical aettings: a comprehensive literature review. Biomedicines 2022; 10: 2697.
  • Kocer D, Karakukcu C, Karaman H, Gokay F, Bayram F. May the neutrophil/lymphocyte ratio be a predictor in the differentiation of different thyroid disorders? Asian Pac J Cancer Prev 2015; 16: 3875-9.
  • Erge E, Kiziltunc C, Balci SB, et al. A novel Iinflammatory marker for the diagnosis of Hashimoto's thyroiditis: platelet-count-to-lymphocyte-count ratio. Diseases. 2023; 11: 15.
  • Cao YT, Zhang KY, Sun J, et al. Platelet abnormalities in autoimmune thyroid diseases: A systematic review and meta-analysis. Front Immunol 2022; 13: 1089469.
  • Onalan E, Donder E. Neutrophil, and platelet to lymphocyte ratio in patients with hypothyroid Hashimoto's thyroiditis. Acta Biomed 2020; 91: 310-4.
  • Bilge M, Yesilova A, Adas M, Helvaci A. Neutrophil- and platelet- to lymphocyte ratio in patients with euthyroid Hashimoto's thyroiditis. Exp Clin Endocrinol Diabetes 2019; 127: 545-9.
  • Sirbe C, Rednic S, Grama A, Pop TL. An update on the effects of Vitamin D on the immune system and autoimmune diseases. Int J Mol Sci 2022; 23: 9784.
  • Khozam SA, Sumaili AM, Alflan MA, Shawabkeh RAS. Association between vitamin D deficiency and autoimmune thyroid disorder: A systematic review. Cureus 2022; 14: e25869.
  • Volpe R. Autoimmune thyroiditis. In: Braverman LE, Utiger RD (eds) Werner and Ingbar’s The Thyroid, 6th ed Philadelphia: JB Lippincott Co.; 1991: 921–41.
  • Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 12: 1115–9.
  • Inoue N, Watanabe M, Ishido N, et al. The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases. Clin Exp Immunol 2014; 178: 262-9.
  • Yazici D, Yavuz D, Tarcin O, Sancak S, Deyneli O, Akalin S. Vitamin D receptor gene ApaI, TaqI, FokI and BsmI polymorphisms in a group of Turkish patients with Hashimoto's thyroiditis. Minerva Endocrinol 2013; 38: 195-201.
  • Tamer G, Arik S, Tamer I, Coksert D. Relative vitamin D insufficiency in Hashimoto's thyroiditis. Thyroid 2011; 21: 891-6.
  • Arslan-Suzen A. Hashimoto thyroiditis, vitamin D, active vitamin D, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio as an indicator of inflammation. Unpublished Ph D Thesis, Health Science University, Department of Internal Medicine, Ankara, 2018. https://tez.yok.gov.tr. (Accessed: 16.04.2023)
  • Dib PRB, Quirino-Teixeira AC, Merij LB, et al. Innate immune receptors in platelets and platelet-leukocyte interactions. Leukoc Biol 2020; 108: 1157-82.
  • Ito S, Fujiwara SI, Murahashi R, et al. Clinical association between thyroid disease and immune thrombocytopenia. Ann Hematol 2021; 100: 345-52.
  • Beyan C, Kaptan K. Reactive thrombocytosis accompanying subclinical hypothyroidism due to Hashimoto's thyroiditis. Blood Coagul Fibrinolysis 2013; 24: 649-51.
  • Deppermann C, Kubes P. Start a fire, kill the bug: The role of platelets in inflammation and infection. Innate immune 2018; 24: 335-48.
  • Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Invest 2005; 115: 3339-47.

The relationship between Hashimoto's thyroiditis and vitamin D and the inflammatory marker platelet-to-lymphocyte ratio

Year 2023, Volume: 6 Issue: 3, 693 - 698, 31.05.2023
https://doi.org/10.32322/jhsm.1293585

Abstract

Aim: Hashimoto's thyroiditis (HT) is a chronic autoimmune-mediated disease that leads to overt hypothyroidism. Vitamin D is essential for immunity. This study examines possible impacts of vitamin D on the progression of HT and evaluates the use of platelet-lymphocyte ratio (PLR) as an indicator of its relationship with the inflammatory process.
Material and Method: This is a retrospective case-control study, consisting of 60 individuals with HT and 40 healthy controls. Thyroid function tests, thyroid antibodies, vitamin D levels, erythrocyte sedimentation rate (ESR), parameters of complete blood count and C-reactive protein (CRP) levels were scanned retrospectively using participants' medical files between September 2018 and March 2019. Platelet count was divided by lymphocyte count to determine PLR.
Results: HT patients had both considerably lower median vitamin D levels and higher percentages of vitamin D deficiency than the controls [12.08 (8.79–17.00) vs. 20.09 (20.00–34.00) and 80% vs. 22.5%, respectively, p<0.001). Vitamin D deficiency was also higher within the hypothyroid HT group than in the euthyroid HT group (p<0.001). The vitamin D levels of HT patients with subclinical hypothyroidism were lower than those with euthyroidism (p<0.004). The study groups showed no differences regarding CRP levels, higher levels of ESR were reported only in the overt hypothyroid patients (p=0.001), and higher PLRs were found in those euthyroid HT patients. Vitamin D was negatively correlated with TSH and anti-thyroid peroxidase (anti-TPO) levels (r=−0.294, p=0.023; r=−0.281, p=0.030, respectively). A positive correlation existed between TSH and anti-TPO (r=0.411, p=0.001) and ESR (r=0.365, p=0.002), but TSH and PLR were negatively correlated (r=−0.390, p=0.002).
Conclusion: According to these findings, vitamin D may play a role in the transition to the hypothyroid phase in HT patients, and thus, vitamin D replacement may inhibit this progression. Moreover, our results indicate that PLR may not be a good inflammatory indicator for vitamin D-deficient HT patients.

References

  • Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T (4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-99.
  • Huber G, Staub JJ, Meier C, et al. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab 2002; 87: 3221-6.
  • Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005; 26: 662-87.
  • Li HS, Verginis P, Carayanniotis G. Maturation of dendritic cells by necrotic thyrocytes facilitates induction of experimental autoimmune thyroiditis. Clin Exp Immunol 2006; 144: 467-74.
  • Jo E-K. Innate immunity to mycobacteria: vitamin D and autophagy. Cell Microbiol 2010; 12: 1026-35.
  • Wang J, Lv S, Chen G, et al. Meta-Analysis of the association between Vitamin D and autoimmune thyroid disease. Nutrients 2015; 7: 2485-98
  • Cvek M, Kaličanin D, Barić A, et al. Vitamin D and Hashimoto’s thyroiditis: observations from CROHT Biobank. Nutrients 2021; 13: 2793.
  • Botelho IMB, Moura Neto A, Silva CA, Tambascia MA, Alegre SM, Zantut-Wittmann DE. Vitamin D in Hashimoto’s thyroiditis and its relationship with thyroid function and inflammatory status. Endocr J 2018; 65: 1029-37.
  • Seo IH, Lee YJ. Usefulness of complete blood count (CBC) to assess cardiovascular and metabolic diseases in clinical aettings: a comprehensive literature review. Biomedicines 2022; 10: 2697.
  • Kocer D, Karakukcu C, Karaman H, Gokay F, Bayram F. May the neutrophil/lymphocyte ratio be a predictor in the differentiation of different thyroid disorders? Asian Pac J Cancer Prev 2015; 16: 3875-9.
  • Erge E, Kiziltunc C, Balci SB, et al. A novel Iinflammatory marker for the diagnosis of Hashimoto's thyroiditis: platelet-count-to-lymphocyte-count ratio. Diseases. 2023; 11: 15.
  • Cao YT, Zhang KY, Sun J, et al. Platelet abnormalities in autoimmune thyroid diseases: A systematic review and meta-analysis. Front Immunol 2022; 13: 1089469.
  • Onalan E, Donder E. Neutrophil, and platelet to lymphocyte ratio in patients with hypothyroid Hashimoto's thyroiditis. Acta Biomed 2020; 91: 310-4.
  • Bilge M, Yesilova A, Adas M, Helvaci A. Neutrophil- and platelet- to lymphocyte ratio in patients with euthyroid Hashimoto's thyroiditis. Exp Clin Endocrinol Diabetes 2019; 127: 545-9.
  • Sirbe C, Rednic S, Grama A, Pop TL. An update on the effects of Vitamin D on the immune system and autoimmune diseases. Int J Mol Sci 2022; 23: 9784.
  • Khozam SA, Sumaili AM, Alflan MA, Shawabkeh RAS. Association between vitamin D deficiency and autoimmune thyroid disorder: A systematic review. Cureus 2022; 14: e25869.
  • Volpe R. Autoimmune thyroiditis. In: Braverman LE, Utiger RD (eds) Werner and Ingbar’s The Thyroid, 6th ed Philadelphia: JB Lippincott Co.; 1991: 921–41.
  • Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 12: 1115–9.
  • Inoue N, Watanabe M, Ishido N, et al. The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases. Clin Exp Immunol 2014; 178: 262-9.
  • Yazici D, Yavuz D, Tarcin O, Sancak S, Deyneli O, Akalin S. Vitamin D receptor gene ApaI, TaqI, FokI and BsmI polymorphisms in a group of Turkish patients with Hashimoto's thyroiditis. Minerva Endocrinol 2013; 38: 195-201.
  • Tamer G, Arik S, Tamer I, Coksert D. Relative vitamin D insufficiency in Hashimoto's thyroiditis. Thyroid 2011; 21: 891-6.
  • Arslan-Suzen A. Hashimoto thyroiditis, vitamin D, active vitamin D, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio as an indicator of inflammation. Unpublished Ph D Thesis, Health Science University, Department of Internal Medicine, Ankara, 2018. https://tez.yok.gov.tr. (Accessed: 16.04.2023)
  • Dib PRB, Quirino-Teixeira AC, Merij LB, et al. Innate immune receptors in platelets and platelet-leukocyte interactions. Leukoc Biol 2020; 108: 1157-82.
  • Ito S, Fujiwara SI, Murahashi R, et al. Clinical association between thyroid disease and immune thrombocytopenia. Ann Hematol 2021; 100: 345-52.
  • Beyan C, Kaptan K. Reactive thrombocytosis accompanying subclinical hypothyroidism due to Hashimoto's thyroiditis. Blood Coagul Fibrinolysis 2013; 24: 649-51.
  • Deppermann C, Kubes P. Start a fire, kill the bug: The role of platelets in inflammation and infection. Innate immune 2018; 24: 335-48.
  • Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Invest 2005; 115: 3339-47.
There are 27 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Original Article
Authors

Gönül Koç 0000-0002-8512-4816

Ayşe Arslan-süzer 0009-0006-7773-4733

Gül Gürsoy 0000-0003-2647-694X

Publication Date May 31, 2023
Published in Issue Year 2023 Volume: 6 Issue: 3

Cite

AMA Koç G, Arslan-süzer A, Gürsoy G. The relationship between Hashimoto’s thyroiditis and vitamin D and the inflammatory marker platelet-to-lymphocyte ratio. J Health Sci Med / JHSM. May 2023;6(3):693-698. doi:10.32322/jhsm.1293585

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].

The Directories (indexes) and Platforms we are included in are at the bottom of the page.

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show







The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.

       images?q=tbn:ANd9GcRB9r6zRLDl0Pz7om2DQkiTQXqDtuq64Eb1Qg&usqp=CAU

500px-WorldCat_logo.svg.png

atifdizini.png

logo_world_of_journals_no_margin.png

images?q=tbn%3AANd9GcTNpvUjQ4Ffc6uQBqMQrqYMR53c7bRqD9rohCINkko0Y1a_hPSn&usqp=CAU

doaj.png  

images?q=tbn:ANd9GcSpOQFsFv3RdX0lIQJC3SwkFIA-CceHin_ujli_JrqBy3A32A_Tx_oMoIZn96EcrpLwTQg&usqp=CAU

ici2.png

asos-index.png

drji.png





The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.

COPE-logo-300x199.jpgimages?q=tbn:ANd9GcQR6_qdgvxMP9owgnYzJ1M6CS_XzR_d7orTjA&usqp=CAU

icmje_1_orig.png

cc.logo.large.png

ncbi.pngimages?q=tbn:ANd9GcRBcJw8ia8S9TI4Fun5vj3HPzEcEKIvF_jtnw&usqp=CAU

ORCID_logo.png

1*mvsP194Golg0Dmo2rjJ-oQ.jpeg


Our Journal using the DergiPark system indexed are;

Ulakbim TR Dizin,  Index Copernicus, ICI World of JournalsDirectory of Research Journals Indexing (DRJI), General Impact FactorASOS Index, OpenAIRE, MIAR,  EuroPub, WorldCat (OCLC)DOAJ,  Türkiye Citation Index, Türk Medline Index, InfoBase Index


Our Journal using the DergiPark system platforms are;

Google, Google Scholar, CrossRef (DOI), ResearchBib, ICJME, COPE, NCBI, ORCID, Creative Commons, Open Access, and etc.


Journal articles are evaluated as "Double-Blind Peer Review". 

Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user.  https//dergipark.org.tr/tr/pub/jhsm/page/9535

Journal charge policy   https://dergipark.org.tr/tr/pub/jhsm/page/10912


Editor List for 2022

Assoc. Prof. Alpaslan TANOĞLU (MD)  

Prof. Aydın ÇİFCİ (MD)

Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)

Prof. Murat KEKİLLİ (MD)

Prof. Yavuz BEYAZIT (MD) 

Prof. Ekrem ÜNAL (MD)

Prof. Ahmet EKEN (MD)

Assoc. Prof. Ercan YUVANÇ (MD)

Assoc. Prof. Bekir UÇAN (MD) 

Assoc. Prof. Mehmet Sinan DAL (MD)


Our journal has been indexed in DOAJ as of May 18, 2020.

Our journal has been indexed in TR-Dizin as of March 12, 2021.


17873

Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.